AxoGen (AXGN) Tops Q3 EPS by 7c

AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.45 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c